This is fundamentally different from the injection site profile of tirzepatide or semaglutide , which generally produce minimal injection site reactions
When to increase dose Consider increasing if: Minimal response after 4-6 weeks at current dose No side effects at current dose Current dose below the higher end of recommended range Goals not being met with conservative approach Increase gradually, typically by 25-50% at a time
Nasal administration provides a convenient, non-invasive option, making it ideal for individuals focused on faster recovery, injury support, and long-term resilience
Use once daily, 12 sprays (625mcg - 1250mcg), with up to 80 uses per bottle
There are also some cases where specific GSTs are not able to conduct peroxidase activity, such as theta class GSTs [134, 135]